Umedica Laboratories Private Limited

Umedica Laboratories Private Limited is a distinguished pharmaceutical manufacturing company dedicated to improving human health worldwide. As a key member of the Amoli Group of Companies, Umedica specializes in the manufacturing and export of a diverse range of pharmaceutical formulations, including injectables, tablets, capsules, suspensions, and dry syrups. With a strong patient-centric approach, Umedica offers a broad product portfolio covering antibiotics, anti-diabetics, anti-hyperlipidemics, anti-hypertensives, non-steroidal anti-inflammatory drugs (NSAIDs), analgesics, antifungals, anti-malarials, antihistamines, psychotropic medications, diuretics, drugs for sexual dysfunction, and multivitamins.

Located in Mumbai, Maharashtra, Umedica Laboratories Private Limited operates with a culture of innovation and continuous improvement to achieve excellence in pharmaceutical manufacturing. Their advanced manufacturing facility in Vapi, Gujarat, is WHO GMP approved and has received approvals from US FDA, EU, Health Canada, TGA, and UAE MoH, as well as regulatory authorities from numerous countries including the USA, EU, Australia, Canada, UAE, and several African nations. Equipped with a state-of-the-art R&D Center staffed by experienced scientists, Umedica is committed to developing new and effective formulations.

Umedica has a significant global presence, with business operations in over 85 countries across the US, EU, Canada, Australia, Middle East, Central & South America, Africa, and Asian & CIS countries. Umedica Laboratories Private Limited is also a Government-recognized Export House, awarded the ‘Chemexcil’ Top Export Award for outstanding export performance. The primary address for Umedica is 302,Dalamal House ,J B Road ,Nariman Point Mumbai , Maharashtra 400021, IN. We invite the manager of Umedica Laboratories Private Limited to create a customized and exclusive company showcase and product listing on our platform to further enhance their market reach.